ID 155 - Witamina D

PL: Witamina D
EN: Vitamin D
Pdf: vitamin D

Oświadczenie (4)

Oświadczenie (2)

1. Charakterystyka żywności / składnika

The food constituent that is the subject of the health claim is vitamin D which is a well recognised nutrient and is measurable in foods by established methods. Vitamin D occurs naturally in foods as vitamin D2 (ergocalciferol) and vitamin D3 (cholecalciferol). Different forms of vitamin D are authorised for addition to foods and for use in food supplements (Annex II of the Regulation (EC) No 1925/20065 and Annex II of Directive 2002/46/EC6). This evaluation applies to vitamin D naturally present in foods and those forms authorised for addition to foods and for use in food supplements (Annex II of the Regulation (EC) No 1925/2006 and Annex II of Directive 2002/46/EC).
The Panel considers that the food constituent, vitamin D, which is the subject of the health claim is sufficiently characterised.

2.2. Utrzymanie prawidłowego funkcjonowania mięśni (ID 155)

The claimed effect is “muscle growth, development and function”. The Panel assumes that the target population is the general population.
The Panel considers that maintenance of normal muscle function is a beneficial physiological effect.

3. Naukowe uzasadnienia wpływu na zdrowie człowieka - 

Vitamin D can be obtained from dietary sources or can be synthesised in the body by exposure to UV-radiation from the sun. Even though it is more suitable to refer to vitamin D as a hormone, vitamin D resembles true vitamins, since humans deprived of solar exposure depend on a food source. Synthesis of vitamin D in the skin by the action of sunlight is insufficient to meet requirements in some European countries, especially during winter months when there is little sunlight exposure.
Vitamin D is biologically inactive and requires successive hydroxylations; first in the liver, where 25-hydroxyvitamin D (25-OHD) is formed, and the next hydroxylation in the kidneys form 1,25-dihydroxyvitamin D (1,25-(OH)2D), which is the biologically active form of vitamin D. 1,25-(OH)2D interacts with a specific nuclear receptor in its target tissues that results in a biological response. The major target tissues for 1,25-(OH)2D are the intestine and bone; however, nuclear receptors for 1,25-(OH)2D have been identified in several other tissues and in cultured tumour cells. Serum concentration of 25-OHD is accepted as a valid marker of vitamin D status.
The principal physiological function of vitamin D in all vertebrates including humans is to maintain serum calcium and phosphorus concentrations in a range that supports cellular processes, neuromuscular function, and bone ossification. Vitamin D accomplishes this goal by enhancing the efficiency of the small intestine to absorb dietary calcium and phosphorous, and by mobilising calcium and phosphorus from the bone.
Vitamin D also has other functions in tissues not primarily related to mineral metabolism. One example is the haematopoietic system, in which vitamin D affects cell differentiation and proliferation including such effects also in cancer cells. Vitamin D furthermore participates in the process of insulin secretion. The active metabolite of vitamin D, 1,25(OH)2D, regulate the transcription of a large number of genes through binding to a transcription factor, the vitamin D receptor (VDR) (SCF, 2002).

3.2. Utrzymanie prawidłowego funkcjonowania mięśni (ID 155)

The evidence provided by consensus opinions/reports from authoritative bodies and reviews shows that there is consensus on the role of vitamin D in normal muscle function (Norman and Henry, 2007; Cotler et al., 2008).
Muscle weakness is a feature of the clinical syndrome of vitamin D deficiency. Clinical symptoms of vitamin D deficiency myopathy include proximal muscle weakness, diffuse muscle pain, and gait impairments such as waddling way of walking (Schott and Wills, 1976; Ceglia, 2008).
The vitamin D receptor is expressed in human muscle tissue, and its activation may promote de novo protein synthesis in muscle (Sorensen et al., 1979).
The Panel considers that a cause and effect relationship has been established between the dietary intake of vitamin D and maintenance of normal muscle function.

4.2. Utrzymanie prawidłowego funkcjonowania mięśni (ID 155)

The following wording reflects the scientific evidence: “Vitamin D contributes to the maintenance of normal muscle function.”.

5. Warunki i możliwe ograniczenia stosowania oświadczenia

The Panel considers that in order to bear the claim a food should be at least a source of vitamin D as per Annex to Regulation (EC) 1924/2006. Such amounts can be easily consumed as part of a balanced diet. The target population is the general population. Tolerable Upper Intake Levels (UL) have been established as 50 μg/day for adults including pregnant and lactating women. For children (0 – 10 years) and adolescents (11 – 17 years) UL were established as 25μg/day and 50μg/day respectively (SCF, 2002).

Warunki i możliwe ograniczenia stosowania oświadczenia

Must at least be a source of vitamin/s as per annex to regulation 1924/2006